Biologics in severe difficult-to-treat asthma: find the right niche!
Humbert M.
Eur Respir Rev 2009; 18: 51-53 |   |
Activity limitation: a major consequence of dyspnoea in COPD
Roche N.
Eur Respir Rev 2009; 18: 54-57 | |
Update on severe asthma: what we know and what we need
Gaga M., Zervas E., Chanez P.
Eur Respir Rev 2009; 18: 58-65 | |
A physiological model of patient-reported breathlessness during daily activities in COPD
Jolley C. J., Moxham J.
Eur Respir Rev 2009; 18: 66-79 |  |
Update on the roles of distal airways in asthma
Burgel P-R., de Blic J., Chanez P., Delacourt C., Devillier P., Didier A., Dubus J-C., Frachon I., Garcia G., Humbert M., Laurent F., Louis R., Magnan A., Mahut B., Perez T., Roche N., Tillie-Leblond I., Tunon de Lara M., Dusser D.
Eur Respir Rev 2009; 18: 80-95 | |
Biomarkers in the management of COPD
Lacoma A., Prat C., Andreo F., Dominguez J.
Eur Respir Rev 2009; 18: 96-104 | |
Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK
Demoly P., Paggiaro P., Plaza V., Bolge S. C., Kannan H., Sohier B., Adamek L.
Eur Respir Rev 2009; 18: 105-112 | |
Metabolic aspects of obstructive sleep apnoea syndrome
Bonsignore M. R., Eckel J.
Eur Respir Rev 2009; 18: 113-124 | |
Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis
Ocak S., Feoli F., Fastrez J., Butenda D., Litvine C., Colin I. M., d'Odemont J-P
Eur Respir Rev 2009; 18: 125-128 | |
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Sakamoto K., Taniguchi H., Kondoh Y., Ono K., Hasegawa Y., Kitaichi M.
Eur Respir Rev 2009; 18: 129-132 | |
Chronic Obstructive Pulmonary Disease (COPD)
Weitzenblum E.
Eur Respir Rev 2009; 18: 133 | |